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Abstract 
 Monilinia vaccinii-corymbosi (Reade) Honey (M.vc), the causal agent of Monilinia blight 
of wild blueberry, is controlled primarily by fungicide applications. Demethylation-inhibiting 
fungicides (DMIs) have been used for over 30 years for Monilinia blight control due to flexibility 
of use (i.e., ability to use after an infection period) and disease control effectiveness and 
consistency. In the present study, the sensitivity of ten M.vc isolates to three DMIs- propiconazole, 
difenoconazole and prothioconazole-desthio were evaluated in vitro by a mycelial growth 
inhibition assay. In addition, four field trials were conducted during two crop seasons: 2012 and 
2013, to examine the efficacy of these DMIs to control Monilinia blight. All the tested DMIs were 
effective in inhibiting mycelial growth of M.vc isolates, although the mean EC50 values differed 
significantly. In field experiments, three of four trials had significant treatment effect on disease 
incidence and severity of vegetative buds. Prothioconazole-desthio and propiconazole provided 
consistent control against Monilinia blight. Conversely, difenoconazole was effective in in vitro 
analysis, but did not demonstrate satisfactory Monilinia blight control in all field trials. In the 2012 
trials, both prothioconazole-desthio and propiconazole reduced disease incidence of vegetative 
buds by 100% compared to the untreated control. Prothioconazole-desthio reduced disease 
development in 2013 with 94 and 99.8% less incidence, and 75 and 99.5% less severity. Similarly, 
propiconazole also reduced incidence of vegetative buds by 88% and 99.8%, and severity by 54% 
and 99.7%. No phytotoxic symptoms were observed in any of the field trials. The results of the 
study serve as a benchmark to monitor shifts in M.vc sensitivity to these fungicides in the future.  
 
Additional Keywords: Monilinia blight, lowbush blueberry, fungicide sensitivity, 
 propiconazole, prothioconazole-desthio, difenoconazole 
 
Introduction 
Monilinia blight, caused by Monilinia vaccinii-corymbosi (Reade) Honey (M.vc), is an 
important yield-limiting, fungal disease of wild blueberries. The disease has two infection phases 
with- the primary infection resulting in blighting of emerging vegetative and floral buds and the 
secondary phase resulting in infection of flowers and developing berries producing pseudosclerotia 
(mummy berries) (Hildebrand et al., 1995). Together, the primary and secondary infection 
processes cause losses in leaf and floral tissue, yield potential and berry quality. Control measures 
such as intense and uniform burning can be effective in destroying mummy berries (Delbridge and 
Hildebrand, 1995), however, sequential burning has a high cost and reduces the organic matter 
content in the soil. Annis and Yarborough (2014) stated that efficient harvest techniques reduces 
the number of infected berries dropping to the ground. Although, these measures reduce the 
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number of infected berries left in the field, they may not give sufficient control of disease (Guo, 
2016). Effective management of the disease relies heavily on the use of fungicide applications. 
 Demethylation inhibitors (DMIs) compose one of the most important group of fungicides 
used for Monilinia blight control in Canada. DMIs specifically target the demethylation process at 
C-14α demethylase and disrupt fungal sterol biosynthesis (Köller, 1988). The Monilinia vaccinii-
corymbosi populations in commercial wild blueberry fields in Nova Scotia have been exposed to 
DMI fungicides for approximately 30 years since the first usage of triforine in the 1980s (Lockhart 
et.al., 1983). It was replaced by propiconazole in the 1990s, and the wild blueberry producers have 
been reliant on propiconazole for Monilinia blight control for past 20 years. Despite a history of 
success in using propiconazole, inconsistent efficacy has been observed in research trials 
conducted in Nova Scotia in 2007, 2008, 2010 (Percival and Beaton, 2012) and 2017. Extensive 
and consecutive use of a specific fungicide can lead to a sensitivity shift toward resistant 
populations of the pathogen to the fungicide (Brent and Hollomon, 2007). Furthermore, cross-
resistance can occur between fungicides that belong to the same chemical group or have the same 
mode of action.  
 Consequently, studies completed by Percival and Beaton (2012) reported prothioconazole-
desthio as an effective Monilinia blight control product, with the additional benefit of no residues 
detected in harvested or processed berries. The importance of assessing other DMIs for Monilinia 
blight became more apparent with propiconazole being declared a human health risk by the 
European Union (WTO, 2018). Since propiconazole has been extensively used for Monilinia blight 
control and site- specific fungicides are prone to resistance development, assessing the sensitivity 
of M.vc to the most commonly used DMI is crucial for Monilinia blight management. This study 
was conducted to determine the sensitivity of M.vc isolates to DMI group fungicides 
(propiconazole, prothioconazole-desthio and difenoconazole) and to investigate the ability of these 
fungicides to control Monilinia blight in commercial wild blueberry fields.  
 
Materials and Methods 
 
Monilinia vaccinii-corymbosi isolates 
 Isolates were collected from mummy berries and Monilinia blighted shoots from five 
commercial wild blueberry fields in Nova Scotia during 2011 to 2013. Mummy berries and 
Monilinia blighted shoots were surface sterilized and blocks of white medulla cut from the center 
of mummy berries and pieces of blighted leaves were inoculated onto potato dextrose agar (PDA) 
plates amended with antibiotics (0.5mg mL-1 streptomycin sulfate, 0.5mg mL-1 penicillin) to 
suppress bacterial growth. Petri dishes were incubated at 22 ± 2 °C for further mycelial growth. 
 
Determination of fungicide sensitivity 
 The fungicides used in this study were the pure technical grade active ingredients: 
propiconazole (Syngenta Honeywood Research Farm, Platisville, ON, CA), prothioconazole-
desthio (Bayer Crop Science, MO, US) and difenoconazole (Syngenta Honeywood Research 
Farm, Platisville, ON, CA). Stock solutions/suspensions of fungicides were prepared by dissolving 
active ingredients in acetone on the day of the experiment. Autoclaved PDA was amended with 0, 
0.005, 0.01, 0.05, 0.1 μg mL-1 propiconazole and difenoconazole and 0, 0.001, 0.002, 0.003, 0.004 
μg mL-1 prothioconazole-desthio. The control medium was not amended with fungicides. In all 
cases, including the control plates, the final acetone concentration was 0.1 % (v/v). Tests for each 
isolate were replicated three times per concentration of each fungicide. 
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 Sensitivity of 10 isolates was estimated based on mycelium growth inhibition assay 
(Golembiewski et al., 1995; Hu et al., 2011; Wise et al., 2011). For each isolate, a 4mm- diameter 
mycelial plug was cut from the edge of a 10-day-old colony grown on PDA medium and placed 
upside down on fungicide- amended and un-amended media. The plates were incubated at 22 ± 2 
°C in the dark. After 7 days, the colony diameter was measured in two perpendicular directions, 
and the diameter of the mycelial plug was subtracted before calculating the mean diameter of the 
colony. For each concentration/fungicide, the EC50 value (effective concentration that reduced 
mycelial growth by 50%) was calculated by regressing the relative growth (RG: colony diameter 
on fungicide-amended medium divided by colony diameter on unamended medium × 100) against 
the log10 fungicide concentration. As per the reports of Thompson and Annis (2014), mean EC50 
value for baseline isolates from unmanaged fields of Maine to propiconazole is 0.016 g μg mL-1. 
Since there were no previous references of M.vc to difenoconazole and prothioconazole-desthio, 
EC50 values lower than the EC50 found for propiconazole (0.016 μg mL-1, (Thompson and Annis, 
2014) were considered “sensitive” (S); EC50 values ranging from 0.016 to 1.0 µg mL-1 were 
considered “moderately sensitive” (MS); and EC50 values above 1.0 µg mL-1 were considered 
“non-sensitive” (NS). The variation factor (VF) to fungicides was calculated as the highest EC50 
value divided by the lowest EC50 value, in order to evaluate the extent of variability in fungicide 
sensitivity among the populations. 
 
Field Experiments 
 Field trials were conducted during 2012 and 2013 to determine the efficacy of the three 
DMIs against natural infections caused by M.vc. Experiments were performed in the cropping 
phase of production in four commercial wild blueberry fields. Two trials were located at 
Kemptown, Nova Scotia (NS) (coordinates = 45° 30´ N, 63° 07´ W) and Aulac, New Brunswick 
(NB) (coordinates = 45° 53´ N, 64° 16´ W) in 2012. The other two field trials were located at Mt. 
Thom, NS (coordinates = 45° 29´ N, 62° 59´ W) and Farmington, NS (coordinates = 45° 34´ N, 
63° 53´ W) in 2013. The trials were in a randomized complete block design with five replications. 
Each plot was 4 × 6 m with 2m buffers between plots. 
 DMI treatments consisted of application of Proline® 480SC (a.i. prothioconazole) at 300 
mL product·ha-1, Tilt® 250E (a.i. propiconazole) at 500 mL product·ha-1, and Inspire® (a.i. 
difenoconazole) at 80 g product·ha-1. A 2000 series Watchdog® weather station (Spectrum 
Technologies, Inc. Plainfield, IL, US) was set up in the center of each trial to monitor air 
temperature, relative humidity, wind speed and direction, and leaf wetness every minute. 
Fungicides were sprayed two times. The first application was done when the field reached to 40 – 
50 % V2 and/or F2 stage (V2: 2 - 5 mm green leaf tissue emerged, F2: floral bud scales separating). 
The second application was done 7 to 9 days after the first application. The timing was decided by 
consulting with the Monilinia forecasting system (which uses temperature, wetness duration, spore 
dispersal, and developing stage of vegetative and/or floral buds), which was available at lowbush 
blueberry blog (provided by Perennia, Truro, NS, CA). In 2012, fungicide applications were made 
on May 2 and May 11 at the Kemptown site and on April 30 and May 8 at the Aulac site. In 2013, 
fungicide applications performed on May 8 and May 17 at the Mt. Thom site and on May 7 and 
May 14 at the Farmington site. Each fungicide was mixed with distilled water and was applied 
using a Bell spray Inc. ® hand held sprayer with a 2-m CO2 propelled boom and 4 TeeJet Visiflow 
8003VS nozzles. The sprayer pressure was 32 PSI (220 kPa). The nozzle discharge rate was 12.5 
mL·s-1 and application ground speed was approximately 1.19 m·s-1.   
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Disease assessment 
 Disease incidence and severity were visually assessed on fifteen randomly selected stems 
per plot using a line transect (samples were collected every 4.5 m along the transect). Since 
symptoms of Monilinia blight do not show until 10 to 17 days after the susceptible buds were 
infected by the ascospores (Delbridge and Hildebrand, 1995), first assessments occurred prior to 
the second fungicide applications, which were 7 to 9 days after first fungicide application. Second 
assessment occurred within 2 weeks after the second fungicide applications.  
Disease incidence was determined by percentage of floral buds and/or vegetative buds per stem 
with visual symptoms of Monilinia blight. While, severity was determined by percentage of 
infected area per flower or leaf with visual symptoms of Monilinia blight within a stem. The 
suppression efficacy of fungicides was determined by comparing the disease incidence and 
severity of wild blueberry plants sprayed with fungicides to the control trials (without fungicide). 
Phytotoxicity was assessed visually by examining the floral/vegetative buds of each stem for 
phytotoxic symptoms. The impact of the treatments on yield potential was determined by 
examining parameters including stem length, number of vegetative nodes, floral nodes, set fruit 
(adequately pollinated and fertilized marketable blueberries) and, pinheads (small under-formed 
and unmarketable blueberries).  
In August, berries were harvested from the field. A forty-tine, commercial wild blueberry hand 
rake was used to harvest berries from four randomly selected 1-m2 quadrats in each plot.  Harvested 
berry yield was recorded using a bench scale. 
 
Data Analysis 
 For in vitro tests, analysis of variance was completed using the PROC Mixed procedure of 
SAS (version 9.3, SAS institute, Inc., Cary, NC), using a factorial design of isolates and active 
ingredients, with the replicate as the blocking factor. Orthogonal contrasts and Tukey’s mean 
comparison test were used. The PROC CORR procedure of SAS was used for correlation analysis. 
For in vivo tests, analysis of variance for all the data collected from the experiment was completed 
using the PROC MIXED procedures of SAS (version 9.3, SAS institute, Inc., Cary, NC). LSD was 
used for multiple means comparison at the level of α = 0.05. 
 
Results and Discussion 
 
Sensitivity of Monilinia vaccinii-corymbosi to DMI fungicides 
 DMI fungicides are the dominant fungicide products for Monilinia blight control in wild 
blueberry production in Nova Scotia due to: their disease control efficiency, ease of use, low cost, 
and economic benefits. However, there is concern that the M.vc populations in commercial wild 
blueberry fields in Nova Scotia may have developed reduced sensitivity to propiconazole because 
of their extensive and consecutive usage for past 20 years. In the present study, none of the tested 
isolates exhibited reduced sensitivity, although, the mean EC50 value differed significantly among 
each of the tested fungicides (Table 1). Prothioconazole-desthio was the most effective inhibitor 
with a mean EC50 of 0.00086 μg·mL-1. Difenoconazole was found to be more effective in inhibiting 
mycelial growth on PDA medium than propiconazole.  
 Although, propiconazole maintained its overall effectiveness against M.vc isolates, 
inconsistency existed among the isolates. This might be due to a relatively wider range observed 
in propiconazole EC50 value than prothioconazole-desthio and difenoconazole (Table 1). This 
inconsistency could be attributed to its erratic efficacy, as observed in the field research trials. 
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Thompson and Annis (2014) found that isolates of M. vaccinii-corymbosi from unmanaged areas 
has EC50 value of 0.016 μg·mL-1 for propiconazole. In our analysis, the mean propiconazole EC50 
value was 0.012 μg·mL-1, which was lower than the baseline value, which indicates the isolates 
are sensitive to propiconazole. Similarly, the isolates were not exposed to prothioconazole-desthio 
and difenoconazole before the year 2014; consequently, data were not available for comparisons. 
Thus, EC50 results of prothioconazole-desthio and difenoconazole provided valuable information 
concerning the normal variation in fungicide sensitivity of M.vc, which can be used as a baseline 
for further sensitivity analysis. 
 
Table 1. Inhibitory effect of each active ingredient on mycelial growth of ten M. vaccinii-
corymbosi isolates from commercial wild blueberry fields in Nova Scotia and their 
comparison using Tukey’s LSD  
Active ingredient  
EC50 values (μg·mL-1)a 
Variation factorc Range Meanb 
Propiconazole 0.008-0.016 0.012 a 2 
Difenoconazole 0.006-0.0083 0.0068 b 1.4 
Prothioconazole-desthio 0.00076-0.0012 0.00086 c 1.6 
a EC50 value is the effective concentration that inhibit mycelial growth by 50%  
b Means that share the same letter is not significant different from each other. Proc Mixed 
procedure was used for analysis of variance (ANOVA)  
c Variation factor = highest EC50 value divided by lowest EC50 value 
 
 It is well documented that different DMIs can show distinct but consistent cross-resistance 
patterns (Hildebrand et al., 1988; Köller & Wubben, 1989; Kendall et al., 1993). Cross-resistance 
is generally accepted to be present among DMI fungicides active against the same fungus 
(Fungicide Resistance Action Committee, 2015) because of their unique mode of action. A study 
by Holb and Schnabel (2007) observed cross-resistance among triazoles by noting their effects on 
M. fructicola on peach.  In this study, propiconazole EC50 values were significantly correlated with 
difenoconazole EC50 values and prothioconazole-desthio EC50 values at the level of α=0.05 (Table-
2). A high correlation between propiconazole and prothioconazole-desthio was found (r = 0.73). 
However, the correlation between propiconazole and difenoconazole was very weak (r = 0.39) 
Correlation implies the possible emergence of cross-resistance among these DMIs. Development 
of reduced sensitivity or resistance of M. vaccinii-corymbosi to propiconazole would have an 
impact on control efficacy of prothioconazole and difenoconazole. A moderate cross-resistance 
between propiconazole and difenoconazole has been reported for Alternaria alternata isolates on 
pistachio (Avenot et al., 2016). As per Thomas et al. (2012), cross-resistance among DMI 
fungicides is not universal. Several studies also documented the lack of cross-resistance among 
DMIs (Leroux et al., 2000; Thomas et al., 2012). Thus, we cannot assume the existence of a 
positive cross-resistance between fungicides with a similar mode of action.  Moreover, the sample 
size used in this study was relatively small. A larger sample size may have provided better 
correlation results.  
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Table 2. Pearson correlation coefficient (r) values of EC50 values for propiconazole, 
 difenoconazole and prothioconazole-desthio  
Active 
ingredient  
  
Difienoconazole 
 
Prothioconazole-desthio 
 
r P-value r 
P-
value 
Propiconazole 0.39 0.038 0.73 <0.001 
Difenoconazole - - 0.17 0.4 
 
Effect of DMI fungicides on Monilinia blight control on field conditions 
 Monilinia blight incidence was observed to be higher on leaf tissues than floral tissues in 
all trials in 2012 and 2013. There was a significant interaction among fungicide treatment and field 
trials. This significance led us to carry out one-way ANOVA for each of the field trials.  In the 
field trials of this study, vegetative and floral buds did not show any Monilinia blight symptoms 
after the first fungicide application. Relatively dry weather at the field trials in 2012 and 2013 
might have contributed to low disease pressure, which was in contrast to severe Monilinia blight 
pressure in 2009 (D. Percival, personal communication, Dalhousie University, NS, CA).  
 Similarly, in the four field experiments, only three fields demonstrated significant 
treatment effects (Table-3). In the trials conducted in 2012, the Aulac trial did not demonstrate 
significant treatment effects. However, the disease incidence and severity of vegetative buds in the 
Kemptown trial ranged from 0 % to 0.3 % and 0 % to 1.01 % respectively. Even though, the 
fungicides did not show a suppressive effect on disease incidence, they significantly lowered 
disease severity by 100 %.  
 In 2013, trials conducted in Farmington and Mt. Thom, the Monilinia blight disease 
pressure was found to be higher than 2012. After the second fungicide application, in the 
Farmington trial, prothioconazole-desthio, propiconazole and difenoconazole lowered disease 
incidence of vegetative buds by 94 %, 88% and 27 % and disease severity by 75 %, 52 % and 10 
% respectively. In the Mt. Thom trial, compared to untreated control, prothioconazole-desthio and 
propiconazole significantly decreased disease incidence and disease severity of vegetative buds by 
100 %. However, difenoconazole lowered disease incidence and severity by 89 % and 86 % 
respectively. No significant treatment effect was observed on the physical development of wild 
blueberry plants or berry yield after the first and second fungicide applications in all trials. This 
might be due to the low disease incidence on floral buds as observed in all field trials (data not 
shown). 
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Table 3. Influence of DMI fungicides on the suppression of Monilinia blight on vegetative  
buds on trials with significant treatment effects after second fungicide application 
 Treatment 
  
2012/Kemptown 2013/Farmington 2013/Mt.Thom 
DIa (%) DSb (%) DIa (%) DSb (%) DIa (%) DSb (%) 
Untreated 0.3 1.01 4.18 15.4 1.22 6.18 
Proline® 480SC  0 0 0.24 3.87 0.003 0.03 
Tilt® 250E 0 0 0.51 7.33 0.003 0.02 
Inspire® 0.07 0.23 3.07 13.8 0.14 0.89 
 ANOVA resultsc NS P=0.04 P=0.02 P=0.048 P=0.01 P=0.02 
a DI (Disease incidence) = 0 to 100% where 0 = no vegetative buds affected and 100 = all vegetative 
buds are affected with at least one lesion.  
b DS (Disease severity) = 0 to 100% where 0 = no disease and 100 = one whole vegetative bud is 
affected 
c Analysis of variance (ANOVA) results refer to treatment effects that were either not significant 
(NS) or significant at p<0.05. Mean separation was completed using LSD multiple means 
comparison test procedure (ά=0.05).  
 
DMIs represent one of the largest groups of systemic fungicides that have been used to 
control agriculturally important fungal pathogens (Zhan et al., 2006). In the present study, 
prothioconazole-desthio and propiconazole provided consistent control against Monilinia blight. 
Among these, prothioconazole-desthio was the most effective fungicide product that showed 
significant reduction in disease incidence and severity of vegetative buds for all trials (Table-3). 
These are similar to the results observed in field research trials conducted in 2009 (Percival and 
Beaton, 2012). However, it should be noted that difenoconazole did not suppress Monilinia blight 
in the field trials, but was effective in in vitro inhibition of mycelial growth. Despite long-term 
use, M.vc populations are still sensitive to propiconazole.  
 
Conclusion 
According to the results from the in vitro sensitivity study of M.vc isolates and in vivo 
fungicide efficacy examination for Monilinia blight control, the M. vaccinii-corymbosi populations 
affecting lowbush blueberry had not developed reduced sensitivity or resistance to the DMIs used 
in this study and this class of fungicides remains the most effective. Besides difenoconazole, the 
in vivo results were consistent with in vitro results that prothioconazole-desthio and propiconazole 
had higher control efficacy against Monilinia blight in field trials. The information presented in 
the study can be used to evaluate population shifts in fungicide sensitivity in subsequent years. 
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